For the quarter ended June 2024, Medical Properties reported revenue of $266.56 million, down 21% over the same period last year. EPS came in at $0.23, compared to -$0.07 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $259.38 million, representing a surprise of +2.77%. The company delivered an EPS surprise of +15.00%, with the consensus EPS estimate being $0.20.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Medical Properties performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Revenues- Straight-line rent
: $38.38 million versus the three-analyst average estimate of $44.86 million. The reported number represents a year-over-year change of -197.6%.Revenues- Interest and other income
: $16.77 million versus $19 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -72.4% change.Revenues- Rent billed
: $183.76 million versus the two-analyst average estimate of $191.09 million. The reported number represents a year-over-year change of -25.8%.Revenues- Income from financing leases
: $27.64 million versus $16.40 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -59.6% change.Net Earnings Per Share (Diluted)
: -$0.54 versus $0.05 estimated by four analysts on average.
View all Key Company Metrics for Medical Properties here>>>Shares of Medical Properties have returned +4.6% over the past month versus the Zacks S&P 500 composite's -6.5% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Image: Bigstock
Compared to Estimates, Medical Properties (MPW) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2024, Medical Properties reported revenue of $266.56 million, down 21% over the same period last year. EPS came in at $0.23, compared to -$0.07 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $259.38 million, representing a surprise of +2.77%. The company delivered an EPS surprise of +15.00%, with the consensus EPS estimate being $0.20.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Medical Properties performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
View all Key Company Metrics for Medical Properties here>>>Revenues- Straight-line rent
: $38.38 million versus the three-analyst average estimate of $44.86 million. The reported number represents a year-over-year change of -197.6%.Revenues- Interest and other income
: $16.77 million versus $19 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -72.4% change.Revenues- Rent billed
: $183.76 million versus the two-analyst average estimate of $191.09 million. The reported number represents a year-over-year change of -25.8%.Revenues- Income from financing leases
: $27.64 million versus $16.40 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -59.6% change.Net Earnings Per Share (Diluted)
: -$0.54 versus $0.05 estimated by four analysts on average.Shares of Medical Properties have returned +4.6% over the past month versus the Zacks S&P 500 composite's -6.5% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.